medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2003, Número 2

<< Anterior Siguiente >>

Ann Hepatol 2003; 2 (2)


Current concepts in alcohol metabolism

Caballería J

Idioma: Ingles.
Referencias bibliográficas: 84
Paginas: 60-68
Archivo PDF: 85.99 Kb.


FRAGMENTO

Sin resumen


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Simpura J. Trends in alcohol consumption in EU countries. In Peters TJ de. Alcohol misuse: An European perspective. Amsterdam, Harwood Academic Publishers, 1996: 1-22.

  2. Grant BF, Dufour MC, Harford TC. Epidemiology of alcoholic liver disease. Sem Liver Dis 1988; 8: 12-25.

  3. Salaspuro M. Epidemiological aspects of alcoholic liver disease, ethanol metabolism and pathogenesis of alcoholic liver injury. In Bircher J, Benhamou JP, McIntyre N, Rizzetto M and Rodés J eds, Oxford Text Book of Clinical Hepatology, 2nd de. Oxford, Oxford University Press, 1999: 1157-1178.

  4. Lieber CS. Ethanol metabolism, cirrhosis and alcoholism. Clin Chim Acta 1997; 257: 59-84.

  5. Bosron WF, Ehrig T, Li T-K. Genetic factors in alcohol metabolism and alcoholism. Sem Liver Dis 1993; 13: 126-135.

  6. Li T-K, Yin S-J, Crabb D, O’Connor S, Ramchandani VA. Genetic and enviromental influences on alcohol metabolism in humans. Alcohol Clin Exp Res 2001; 25: 136-144.

  7. Jornvall H, Höög J-A. Nomenclature of alcohol dehydrogenases. Alcohol 1995; 30: 153-161.

  8. Bosron WF, Li T-K. Genetic polymorphisms of human alcohol and aldehyde dehydrogenase, and their relationship to alcohol metabolism and alcoholism. Hepatology 1986; 6: 502-510.

  9. Li T-K. Pharmacokinetics of responses to alcohol and genes that influence alcohol drinking. J Stud Alcohol 2000; 61: 5-12.

  10. Shen YC, Fan JH, Edenberg HJ, Li T-K, Cui Y-H, Wang Y-E et al. Polymorphism of ADH and ALDH genes among four ethnic groups in China an effects upon the risk for alcoholism. Alcohol Clin Exp Res 1997; 21: 1272-1277.

  11. Chao Y-C, Young TH, Tang H-S, Hsu CT. Alcoholism and alcoholic organ damage and genetic polymorphisms of alcohol metabolizing enzymes in chinese patients. Hepatology 1997; 25: 112-117.

  12. Couzigou P, Coutelle C, Fleury B, Iron A. Alcohol and aldehyde dehydrogenase genotypes, alcoholism and alcohol related diseases. Alcohol Alcohol 1994; 2: 21-27.

  13. Whitfield JB. Meta-analysis of the effects of alcohol dehydrogenase genotype on alcohol dependence and alcoholic liver disease. Alcohol Alcohol 1997; 32: 613-619.

  14. Borras E, Coutelle C, Rosell A, Fernandez-Muixi F, Broch M, Crosas B, Hjelmqvist L et al. Genetic polymorphism of alcohol dehydrogenase in europeans: The ADH2*2 allele decreases the risk for alcoholism and is associated with ADH3*1. Hepatology 2000; 31: 984-989.

  15. Poupon RE, Nalpas B, Coutelle C, Fleury B, Couzigou P, Higueret D and the French Group for Research on Alcohol and Liver. Polymorphism of alcohol dehydrogenase, alcohol and aldehyde dehydrogenase activities: implications in alcoholic cirrhosis in white patients. Hepatology 1992; 15: 1017-1022.

  16. Parés X, Farrés J, Parés A, Soler X, Panés J, Ferré JL, Caballería J et al. Genetic polymorphism of liver alcohol dehydrogenase in Spanish subjects: significance of alcohol consumption and liver disease. Alcohol Alcohol 1994; 29: 701-705.

  17. Blasco C, Caballería J, Parés A, Lligoña A, Deulofeu R, Lluis J, Caballería L et al. Genetic polymorphisms of alcohol metabolizing enzymes do not influence the development of alcoholic liver disease. J Hepatol 2002; 36 (suppl 1): 143.

  18. Mizoi Y, Yamamoto K, Ueno Y, Fukunaga T, Harada S. Involvement of genetic polymorphism of alcohol and aldehyde dehydrogenases in individual variation of alcohol metabolism. Alcohol Alcohol 1994; 29: 707-710.

  19. Allali-Hassani A, Martinez SE, Peralba JM, Vaglenova J, Vidal F, Richart C, Farrés J et al. Alcohol dehydrogenase in human and rat blood vessels. FEBS Lett 1997; 405: 26-30.

  20. Hernández-Muñoz R, Caballería J, Baraona E, Uppal R, Greenstein R, Lieber CS. Human gastric alcohol dehydrogenase: Its inhibition by H2-receptor antagonists and its effect on the bioavailability of ethanol. Alcohol Clin Exp Res 1990; 14: 946-950.

  21. Moreno A, Parés X. Purification and characterization of a new alcohol dehydrogenase from human stomach. J Biol Chem 1991; 266: 1128-1133.

  22. Yin S-J, Wang M-F, Liao C-S, Chen C-M, Wu C-W. Identification of a human stomach alcohol dehydrogenase with distinctive kinetic properties. Biochem Int 1990; 22: 829-835.

  23. Julkunen RJH, DiPadova C, Lieber CS. First pass etabolism of ethanol: a gastrointestinal barrier againts the systemic toxicity of ethanol. Life Sci 1985; 37: 567-573.

  24. Caballería J, Frezza M, Hernández-Muñoz R, DiPadova C, Korsten MA, Baraona E, Lieber CS. The gastric origin of the first-pass metabolis of ethanol in humans: effect of gastrectomy. Gastroenterology 1989; 97: 1205-1209.

  25. Dohmen K, Baraona E, Ishibashi H, Pozzato G, Moretti M, Matsunaga C, Fujimoto K, Lieber CS. Ethnic differences in gastric sigma alcohol dehydrogenase activity and ethanol first-pass metabolis. Alcohol Clin Exp Res 1996; 20: 1569-1576.

  26. Seitz HK, Egerer G, Simanowski UA, Waldherr R, Eckey R, Agarwal DP, Goedde HW, Von Warburg JP. Human gastric alcohol dehydrogenase activity: effect of age, gender and alcoholism. Gut 1993; 34: 1433-1437.

  27. Baraona E, Abittan CS, Dohmen K, Moretti M, Pozzato G, Chayes ZW, Schaefer C, Lieber CS. Gender differences in pharmacokinetics of alcohol. Alcohol Clin Exp Res 2001; 25: 502-507.

  28. Frezza M, DiPadova C, Pozzato G, Terpin M, Baraona E, Lieber CS. High alcohol blood levels in women: the role of decreased gastric alcohol dehydrogenase activity and first-pass metabolism. N Engl J Med 1990; 322: 95-99.

  29. Roine RP, Gentry RT, Hernández-Muñoz R, Baraona E, Lieber CS. Aspirin increases blood alcohol concentrations in human after ingestion of ethanol. JAMA 1990; 264: 2406-2408.

  30. Caballería J, Baraona E, Rodamilans M, Lieber CS. Effects of cimetidine on gastric alcohol dehydrogenase activity and blood ethanol levels. Gastroenterology 1989; 96: 388-392.

  31. Hernández-Muñoz R, Caballería J, Uppal R, Greenstein R, Lieber CS. Human gastric alcohol dehydrogenase: its inhibition by H2-receptor antagonists, and its effects on the bioavailability of ethanol. Alcohol Clin Exp Res 1990; 14: 946-950.

  32. Pestalozzi DM, Buhler R, von Warburg JP, Hess M. Immunohistochemical localization of alcohol dehydrogenase in the human gastrointestinal tract. Gastroenterology 1983; 85: 1011-1016.

  33. Jokelainen K, Siitonen A, Jousimies-Somer H, Nosova T, Heine R, Salaspuro M. In vitro alcohol dehydrogenase-mediated acetaldehyde production by aerobic bacterial representing the normal colonic flora in man. Alcohol Clin Exp Res 1996; 20: 967-972.

  34. Salaspuro M. Bacteriocolonic pathway for ethanol oxidation. Ann Med 1996; 28: 195-200.

  35. Lieber CS. Hepatic metabolic and toxic effects of ethanol: 1991 update. Alcohol Clin Exp Res 1991; 15: 573-592.

  36. Lieber CS. Microsomal ethanol-oxidizing system (MEOS): the first 30 years (1968-1998)-a review. Alcohol Clin Exp Res 1999; 23: 991-1007.

  37. Lieber CS, DeCarli LM. Hepatic microsomal ethanol oxidizing system: In vitro characteristics and adaptative properties in vivo. J Biol Chem 1970; 245: 2505-2512.

  38. Hu Y, Hakkola J, Oscarson M, Ingelman-Sundberg M. Structural and functional characterization of the 5’ flanking region of the rat and human cytochrome P450 2E1 genes: identification of a polymorphic repeat in the human gene. Biochem Biophys Res Commun 1999; 263: 286-293.

  39. Maezawa Y, Yamauchi M., Toda G. Association between restriction fragment length polymorphism of the human cytochrome P450IIE1 gene and susceptibility to alcoholic liver cirrhosis. Am J Gastroenterol 1994; 89: 561-565.

  40. Carr LG, Hartleroad JY, Liang Y, Mendenhall C, Moritz T, Thomasson H. Polymorphis at the P450IIE1 locus is not associated with alcoholic liver disease in caucasian men. Alchol Clin Exp Res 1995; 19: 182-184.

  41. Lucas D, Ménez C, Floch F, Gourlaouen Y, Sparfel O, Joannet I, Bodénez P et al. Cytochromes P4502E1 and P4501A1 genotypes and susceptibility to cirrhosis or upper aerodigestive tract cancer in alcoholic caucasians. Alcohol Clin Exp Res 1996; 20: 1033-1037.

  42. Dupont I, Lucas D, Clot P, Menez C, Albano E. Cytochrome P4502E1 inducibility and hydroxyeyhyl radical formation among alcoholics. J Hepatol 1998; 28: 564-571.

  43. Nieto N, Friedman SL, Greenwel P, Cederbaum AI. CYP2E1-mediated oxidative stress induces collagen type I expression in rat hepatic stellate cells. Hepatology 1999; 30: 987-996.

  44. Lieber CS. Interaction of ethanol with drugs, hepatotoxic agents, carcinogens and vitamins. Alcohol Alcohol 1990; 25: 157-176.

  45. Kater RMH, Roggin G, Tobon F, Zieve P, Iber FL. Increased rate of clearance of drugs from the circulation of alcoholics. Am J Med Sci 1969; 258: 35-39.

  46. Teschke R, moreno F, Petrides AS. Hepatic microsomal ethanol oxidizing system (MEOS): respective role of ethanol and carbohydrates for the enhanced activity after chronic alcohol consumption. Biochem Pharmacol 1981; 30: 45-51.

  47. Joly J-G, Hetu C. Effects of chronic ethanol administration in the rat: relative dependency on dietary lipids. Biochem Pharmacol 1975; 124: 1475-1480.

  48. Mitchell JR, Mack C, Mezey E, Maddrey WC. The effects of variation in dietary protein and ethanol on hepatic microsomal drug metabolism in the rat. Hepatology 1981; 1: 336-340.

  49. Badger TM, Ronis MJJ, Seitz HK, Albano E, Ingelman-Sunberg M, Lieber CS. Alcohol metabolism: role in toxicity and carcinogenesis. Alcohol Clin Exp Res 2003; 27: 336-347.

  50. Seeff LB, Cuccherini BA, Zimmerman HJ, Adler E, Benjamin SB. Acetaminophen hepatotoxicity in alcoholics. Ann Intern Med 1986; 104: 399-404.

  51. Seitz HK, Pöschl G, Simanowski UA. Alcohol and cancer. Recent Dev Alcohol 1998; 14: 67-95.

  52. Lieber CS, Garro A, Leo MA, Mak KM, Worner TM. Alcohol and cancer. Hepatology 1986; 6: 1005-1019.

  53. Seitz HK. Ethanol and retinoid metabolism. Gut 2000; 748-750.

  54. Handler JA, Thurman RG. Fatty acid dependent ethanol metabolism. Biochem Biophys Res Commun 1985; 133: 44-51.

  55. Handler JA, Thurman RG. Redox interactions between catalase and alcohol dehydrogenase pathways of ethanol metabolism in perfused rat livers. J Biol Che 1990; 265: 1510-1515.

  56. Kato S, Alderman J, Lieber CS. Respective roles of ethanol oxidixing system (MEOS) and catalase in ethanol metabolism by deermice lacking alcohol dehydrogenase. Arch Biochem Biophys 1987; 586-591.

  57. Laposata EA, Lange LG. Presence of nonoxidative ethanol metaolis in human organs commonly damaged by ethanol abuse. Science 1986; 231: 497-499.

  58. Peng G-S, Wang –F, Chen C-Y, Luu S-U, Chou H-C, Li T-K, Yin S-J. Involvement of acetaldehyde for full protection against alcoholism by hoozygosity of the variant allele of aldehyde dehydrogenase gene in Asians. Pharmacogenetics 1999; 9: 463-476.

  59. Crabb DW, Edenberg HJ, Bosron WF, Li T-K. Genotypes for aldehyde dehidrogenase deficiency and alcohol sensitivity: The inactive ALDH2 allele is dominant. J Clin Invest 1989; 83: 314-316.

  60. Farrés J, Wang X, Takahashi K, Cunningham SJ, Wang TT, Weiner H. Effects of changing glutamate 487 to lysine in rat and human liver aldehyde dehydrogenase. A model to study (Oriental type) class 2 aldehyde dehydrogenase. J Biol Che 1994; 269: 13854-13860.

  61. Yoshida A. Molecular genetics of human aldehyde dehydrogenase. Pharacogenetics 1992; 2: 139-147

  62. Okamoto K, Murawaki Y, Yuasa I, Kawasaki H. Effect of ALDH2 and CYP2E1 gene polymorphisms on drinking behaviour and alcoholic liver disease in Japanese male workers. Alcohol Clin Exp Res 2001; 25: 19S-23S.

  63. 63, Chou W_Y, Stewart MJ, Carr LG, Zheng D, Stewart TR, Williams A, Pinaire j et al. An A/G polymorphism in the promoter of mitochondrial aldehyde dehydrogenase (ALDH2): Effects of the sequence variant on transcription factor binding and promoter strength. Alcohol Clin Exp Res 1999; 23: 963-968.

  64. Harada S, Okubo T, Nakamura T, Fujii C, Nomura F, Higuchi S, Tsutsui M. A novel polymorphism (-357 G/A) of the ALDH2 gene: Linkage disequilibrium and an association with alcoholism. Alcohol Clin Exp Res 1999; 23: 958-962.

  65. Lieber CS. Acetaldehyde and acetate. In Lieber Cs de, Medical and nutritional complications of alcoholism. Mechanisms and management. New York, Plenum Medical Book Company 1992: 37-57.

  66. Tsukamoto H, Lu SC. Current concepts in the pathogenesis of alcohol liver injury. FASEB J 2001; 15: 1355-1349.

  67. Fernández Checa JC, Bellentani S, Tiribelli C. Alcohol-induced liver disease: from molecular damage to treatment. Rev Med Chile 2002; 130: 681-690.

  68. Hoerner M, Behrens UJ, Worner T, Lieber CS. Humoral immuneresponses to acetaldehyde adducts in alcoholic patients. Res Commun Chem Pathol Pharmacol 1986; 54: 3-12.

  69. Hasamura Y, Teschke R, Lieber CS. Acetaldehyde oxidation by hepatic mitochondria. Decrease after chronic etahnol consumption. Science 1975; 189: 727-729.

  70. Gentry RT. Effects of food on the pharmacokinetics of alcohol absorption. Alcohol Clin Exp Res 2000; 24: 403-404.

  71. Marshall AW, Kingstone D, Boss M, Morgan MY. Ethanol elimination in males and females: Relationship to menstrual cycle and body composition. Hepatology 1983; 3: 701-706.

  72. Wilson JS, Korsten MA, Lieber CS. The combined effects of protein deficiency and chronic ethanol administration on rat ethanol metabolism. Hepatology 1986; 6: 823-829.

  73. Carmichael FJ, Saldivia V, Varghese GA, Israel Y, Orrego H. Ethanol-induced increase in portal blood flow. Role of acetate And A1 and A2 adenosine receptors. Am J Physiol 1988; 2225: G417-G423.

  74. Pinkston JN, Soniman KFA. Effect of lifgt and fasting on the circadian variation of ethanol metabolism in the rat. J Interdisc Cycle Res 1979; 10: 185-193.

  75. Brown SS, Forrest JAH, Roscoe P. A controlled trial of fructose in the treatment of acute alcoholic intoxication. Lancet 1972; 2: 898-900.

  76. Eriksson CJP, Deitrich RA. Metabolic mechanisms in tolerance and physical dependence on alcohol. In Kissin B and Begleiter H eds. The pathogenesis of alcoholism: biological factors. New York, Plenum Press, 1983: 253-283.

  77. Panes J, Caballería J, Guitart R, Parés A, Soler X, Rodamilans M, Navasa M et al. Determinants of ethanol and acetaldehyde metabolism in chronic alcoholics. Alcohol Clin Exp Res 1993; 17: 48-53.

  78. Bernstein J, Videla L, Israel Y. Metabolic alterations produced in liver by chronic ethanol administration. Changes related to energetic parameters of the cell. Biochem J 1973; 134: 515-522.

  79. Cederbaum AI, Dicker E, Lieber CS, Rubin E. Factors contributing to the adaptative increase in ethanol metabolism due to chronic consumption of ethanol. Alcohol Clin Exp Res 1977; 1: 27-31.

  80. Nuutinen H, Lindros K, Salaspuro M. Determinants of blood acetaldehyde level during ethanol oxidation in chronic alcoholics. Alcohol Clin Exp Res 1983; 7: 163-168.

  81. Korri UM, Nuutinen H, Salaspuro M. Increased blood acetate: A new marker of alcoholism and heavy drinking. Alcohol Clin Exp Res 1985; 9: 468-471.

  82. Panés J, Soler X, Parés A, Caballería J, Farrés J, Rodés J, Parés X. Influence of liver disease on hepatic alcohol and aldehyde dehydrogenases. Gastroenterology 1989; 97: 708-714.

  83. Matthewson K, Almardini H, Bartlett K, Record CO. Impaired acetaldehyde metabolism in patients with non-alcoholic liver disorders. Gut 1986; 27: 756-764.

  84. Hoerner M, Behrens UJ, Worner TM, Blacksberg I, Braly LF, Scaffner F, Lieber CS. The role of alcoholism and liver disease in appearance of serum antibodies against acetaldehyde adducts. Hepatology 1988; 8: 569-574.




2020     |     www.medigraphic.com